Replies to post #40017 on Bioelectronics Corp (BIEL)

[Dubb10]

The focus of my questioning revolves around the idea of a share buyback plan with a share structure of 6B (and growing) Outstanding Shares.

[Dubb10]

Sorry, it was "obscene offer":

I'll sell the company when I get an obscene offer, and so far the offers we've received have been nowhere near obscene,

http://ww2.gazette.net/stories/02082011/businew192334_32552.php

Keep in mind the revenue in 2011 was $1.176M (http://www.otcmarkets.com/financialReportViewer?symbol=BIEL&id=76966) vs. $665k in 2013 (http://www.otcmarkets.com/financialReportViewer?symbol=BIEL&id=118081) where at both times FDA decisions that would benefit the company were "close". That's if you are assuming that FDA clearance happens this year. If I'm thinking of a buyout, why would I offer more than the "nowhere near obscene" offers that were made back in 2011?

Similar rumors years ago too (O/S around 1.3B to 1.4B):
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=44302205

[Simpsonly]

So, having addressed at least a dozen topics, I'm still wondering about your CV on management experience in Pharma/Medical projects having to do with the FDA and M&A experience which you left unanswered? By the way, $7.8Million at this game really is chicken feed. We've seen a couple of Billion shares change hands in the last few months - I it MM's churning or someone buying? Thanks